ovarian cancer

Open Access
Splenectomy in Ovarian Cancer Cytoreductive Surgery: Pre-operative Prediction of Disease, Peri-operative Outcomes and Post-operative Adherence to Antimicrobial Prophylaxis and Immunisation
ANDREI CORHA, RADHA GRAHAM, DHIVYA CHANDRASEKARAN, NICOLA D. MACDONALD, KHALED DAWAS and IOANNIS C. KOTSOPOULOS

In Vivo January 2026, 40 (1) 303-310; DOI: https://doi.org/10.21873/invivo.14193
Open Access
Ovarian Cancer and the Risk of Cataract Episodes: A Nationwide Cohort Study
CHIA-YI LEE, SHUN-FA YANG, ELSA LIN-CHIN MAI, YU-LING CHANG, JING-YANG HUANG and CHAO-KAI CHANG

In Vivo July 2025, 39 (4) 2302-2310; DOI: https://doi.org/10.21873/invivo.14026
Open Access
Evaluation of ChatGPT’s Potential in Tailoring Gynecological Cancer Therapies
ANNIKA KRÜCKEL, LENA BRÜCKNER, IASON PSILOPATIS, PETER A. FASCHING, MATTHIAS W. BECKMANN and JULIUS EMONS

In Vivo July 2024, 38 (4) 1649-1659; DOI: https://doi.org/10.21873/invivo.13614
Open Access
Successful Management of Ovarian Cancer Progressing on Olaparib by Niraparib Following Cytoreduction: A Case Report
YUTA ENDO, NORIHITO KAMO, ASAMI KATO, TETSU SATO, CHIKAKO OKABE, SHIGENORI FURUKAWA, TAKAFUMI WATANABE and SHU SOEDA

In Vivo March 2024, 38 (2) 958-962; DOI: https://doi.org/10.21873/invivo.13527
Open Access
Platinum-free Interval May Predict Duration of Maintenance Bevacizumab and Survival in Platinum-sensitive Recurrent Ovarian Cancer
SOO HYUN OH, SOO JIN PARK, SEUNGMEE LEE, SEUNGHO LEE and HEE SEUNG KIM

In Vivo January 2024, 38 (1) 467-473; DOI: https://doi.org/10.21873/invivo.13461
Open Access
Validity of the 2014 FIGO Stage IIIA1 Subclassification for Ovarian, Fallopian Tube, and Peritoneal Cancers
AYUMU MATSUOKA, SHINICHI TATE, KYOKO NISHIKIMI, MASAMI IWAMOTO, SATOYO OTSUKA and MAKIO SHOZU

In Vivo September 2022, 36 (5) 2453-2460; DOI: https://doi.org/10.21873/invivo.12980
Open Access
Mode of Referral of Ovarian Cancer Patients: Does it Alter Treatment and Survival?
ANAS BARAKAT, AEMN ISMAIL, QUENTIN DAVIES and SUPRATIK CHATTOPADHYAY

In Vivo July 2022, 36 (4) 1834-1840; DOI: https://doi.org/10.21873/invivo.12900
Open Access
Survival Outcomes With Reduced Doses of Adjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer
JUHUN LEE, JONG MI KIM, YOON HEE LEE, GUN OH CHONG and DAE GY HONG

In Vivo July 2022, 36 (4) 1868-1874; DOI: https://doi.org/10.21873/invivo.12905
Open Access
Comparison of Survival Outcomes According to BRCA1/2 Variant Type in High-grade Serous Ovarian Cancer
JUHUN LEE, JONG MI KIM, YOON HEE LEE, GUN OH CHONG, NAN YOUNG LEE, IN HEE LEE, JI YOUNG PARK and DAE GY HONG

In Vivo July 2022, 36 (4) 1903-1910; DOI: https://doi.org/10.21873/invivo.12910
Open Access
The Impact of COVID-19 Infection During the Postoperative Period After Surgery for Ovarian Cancer
NICOLAE BACALBASA and IRINA BALESCU

In Vivo May 2022, 36 (3) 1337-1341; DOI: https://doi.org/10.21873/invivo.12835

Main menu

User menu

Search

ovarian cancer

Pages